Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesEbos Group Ltd

Ebos Group Ltd

Healthcare Medical Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
17.29 AUD -0.11 ( 0.63%)
Last update at 2026-11-06T05:10:00Z
VOLUME
74753
Market Cap
3637.69M
P/E
15.13

Momentum Score

…

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; pharmacy data, consumer loyalty, and analytics services; and health communications, programs, and consultancy services. It also offers community-based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five-step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; dog and cat food, and treats; and surgical devices and medical consumables. Further, it provides pet nutrition, treats, clean-up, and grooming products and accessories; supplies pet medicines and other products to veterinary clinics and specialty retailers; manufactures and supplies dog rolls; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
17.16
Low
17.54
High
52 Week Price Range
14.87
Low
24.83
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Ebos Group Limited is a distributor of healthcare and animal-care products in Australia and New Zealand, supplying pharmaceuticals, medical consumables and logistics services to pharmacies, hospitals, aged care and veterinary customers. Long-term growth may be driven by demographic-driven healthcare demand, geographic expansion and scale in distribution plus recurring contract revenues that could support predictable cash flow.

Principal risks are regulatory and reimbursement changes, competitive pressure and loss of key contracts, and execution risk from acquisitions and cross-border integration.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
17.40
Dividend Yield
5.75%
Revenue TTM
13486.68M
Revenue Per Share
65.76
Gross Profit TTM
1743.25M
Debt / Equity
0.26
ROE
8.33%
Net Debt
466.04M
ROCE
7.30%
Diluted EPS TTM
1.15

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 284.40M 325.45M 418.60M 406.39M 327.37M
Minority interest - -0.68M -1.68M -10.96M 0.63M
Net income 214.01M 231.66M 296.71M 275.74M 224.64M
Selling general administrative - 632.72M 619.43M 578.28M 467.06M
Selling and marketing expenses - - 117.61M - -
Gross profit 909.03M 1762.86M 1784.21M 1698.92M 1380.71M
Reconciled depreciation - 158.18M 140.81M 135.80M 90.78M
Ebit - 421.73M 509.61M 495.06M 365.49M
Ebitda 359.28M 579.91M 650.42M 630.86M 456.27M
Depreciation and amortization - 158.18M 140.81M 135.80M 90.78M
Operating income 359.28M 455.58M 527.24M 483.20M 382.22M
Other operating expenses 12458.05M 12753.10M 13883.87M 10402.47M 9496.65M
Interest expense 118.71M 96.28M 109.11M 73.79M 25.44M
Tax provision - 93.12M 120.21M 119.69M 103.35M
Interest income - 7.64M 8.00M 9.30M 3.06M
Net interest income - -114.62M -102.30M -76.79M -31.81M
Income tax expense 69.52M 93.12M 120.21M 119.69M 103.35M
Total revenue 12817.33M 13208.68M 14411.12M 13317.45M 11901.67M
Total operating expenses 549.75M 1307.28M 1256.96M 1199.92M 985.25M
Cost of revenue 11908.30M 11445.81M 12626.91M 11618.53M 10520.96M
Total other income expense net -74.88M -130.13M -108.64M -15.82M -36.29M
Net income from continuing ops - 232.33M 298.39M 286.70M 224.01M
Net income applicable to common shares - - - 253.37M 202.60M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 7817.64M 7837.02M 7368.95M 7005.15M 6945.94M
Intangible assets 670.98M 608.00M 579.01M 560.74M 267.56M
Other current assets 126.18M 46.10M 65.89M 68.81M 58.27M
Total liab 5112.79M 4904.08M 4726.36M 4498.50M 4560.36M
Total stockholder equity 2746.50M 2949.89M 2678.11M 2649.25M 2511.16M
Other current liab 398.32M 383.20M 337.63M 620.43M 827.05M
Common stock - 2433.05M 2116.71M 2056.66M 2007.50M
Capital stock - 2433.05M 2116.71M 2056.66M 2007.50M
Retained earnings 516.25M 540.60M 574.13M 608.80M 534.06M
Other liab - - - 284.94M 327.90M
Good will - 2417.34M 2259.28M 2150.80M 2372.81M
Other assets - - - 208.60M 182.16M
Cash 238.93M 198.40M 236.98M 230.59M 573.58M
Total current liabilities 2893.36M 2815.68M 3413.89M 2892.65M 2784.82M
Current deferred revenue - - - -98.62M -416.90M
Net debt 466.04M 1547.97M 1558.22M 1165.59M 1253.23M
Short term debt 151.16M 87.91M 899.20M 100.41M 414.84M
Short long term debt - 17.00M 836.66M 45.84M 367.58M
Short long term debt total 704.97M 1746.37M 1795.20M 1396.17M 1826.82M
Other stockholder equity 2230.26M - 0.00M -2657.78M -2534.05M
Property plant equipment - - - 660.67M 576.98M
Total current assets 3359.97M 3322.99M 3258.51M 3272.26M 3398.00M
Long term investments - 71.51M 61.67M 58.39M 65.86M
Net tangible assets - - - -57.24M -116.54M
Short term investments - - - 14.73M 17.02M
Net receivables 1602.62M 1629.99M 1633.05M 1629.69M 1524.26M
Long term debt - 1170.15M 513.66M 1018.99M 1160.06M
Inventory 1392.25M 1448.51M 1322.60M 1343.17M 1241.88M
Accounts payable 2343.88M 2344.57M 2177.06M 2270.42M 1959.83M
Accumulated other comprehensive income - -23.77M -12.72M -16.21M -30.40M
Non currrent assets other 3.94M 36.96M 37.67M 19.17M 1.51M
Non current assets total 4457.67M 4514.04M 4110.43M 3732.89M 3547.94M
Capital lease obligations - 559.22M 444.88M 331.34M 299.18M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -397.17M -413.16M -167.88M -7.90M
Change to liabilities - - - 270.73M 414.97M
Total cashflows from investing activities -258.40M -397.17M -408.74M -154.26M -1396.20M
Net borrowings - -151.85M 281.35M -450.62M 864.52M
Total cash from financing activities -11.73M -91.41M 37.51M -595.42M 1664.95M
Change to operating activities - - - 20.56M 117.91M
Net income 214.01M 231.66M 297.34M 274.94M 223.98M
Change in cash 54.73M -35.14M 5.46M -332.39M 386.25M
Begin period cash flow 184.19M 233.53M 231.52M 562.97M 187.33M
End period cash flow 238.93M 198.40M 236.98M 230.59M 573.58M
Total cash from operating activities 331.60M 450.63M 381.31M 424.69M 274.98M
Issuance of capital stock - 268.96M 1.76M 86.21M 877.27M
Depreciation - - 141.11M 135.41M 90.51M
Other cashflows from investing activities -5.80M -125.12M -57.71M - -
Dividends paid 121.79M -147.56M -170.59M -191.24M -170.87M
Change to inventory - - 26.06M -141.35M -352.89M
Change to account receivables - - 3.24M -133.94M -240.55M
Sale purchase of stock - - - 26.05M 1287.16M
Other cashflows from financing activities 105.83M -60.96M -75.01M -53.31M -45.39M
Change to netincome - - - 15.58M -20.04M
Capital expenditures 124.84M 54.25M 92.33M 107.03M 99.38M
Change in working capital -9.82M - -64.07M -275.29M -593.44M
Stock based compensation - - 12.91M 9.78M 6.93M
Other non cash items 127.41M 450.63M 445.38M 14.34M -39.51M
Free cash flow 206.76M 396.38M 288.18M 317.66M 175.59M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
EBO
Ebos Group Ltd		 -0.11
0.63%		 17.29 15.13 18.08 0.27 1.34 0.39 9.21
SIG
Sigma Healthcare Ltd		 -
-%		 2.82 47.00 32.15 3.00 6.45 3.15 30.00
PGC
Paragon Care Ltd		 -0.01
3.23%		 0.15 - 5.98 0.07 0.84 0.17 13.27
MYX
Mayne Pharma Group Ltd		 0.37
13.65%		 3.08 8.74 263.16 0.58 0.55 0.47 1.28

Profile*

Ebos Group Ltd

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; pharmacy data, consumer loyalty, and analytics services; and health communications, programs, and consultancy services. It also offers community-based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five-step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; dog and cat food, and treats; and surgical devices and medical consumables. Further, it provides pet nutrition, treats, clean-up, and grooming products and accessories; supplies pet medicines and other products to veterinary clinics and specialty retailers; manufactures and supplies dog rolls; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

737 Bourke Street, Docklands, VIC, Australia, 3008

61 3 9918 5555

https://www.ebosgroup.com

5009

Name Title Year Born
Mr. John Cullity Chief Exec. Officer NA
Mr. Leonard Hansen CFO & Chief Accountant NA
Ms. Andrea Bell Chief Information Officer NA
Martin Krauskopf Exec. GM of Strategy, Mergers & Acquisitions and GM of Investor Relations NA
Ms. Janelle Cain Gen. Counsel NA
Ms. Jacinta McCarthy Group Gen. Mang. of HR NA
Mr. Simon Bunde Exec. Gen. Mang. of Strategic Operations, ESG & Innovation NA
Ms. Julie Dillon Chief Exec. Officer of Animal Care NA
Mr. Matthew Muscio Chief Exec. Officer of Medical Technology NA
Mr. Brett Barons Chief Exec. Officer of Symbion NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…